ABSTRACT
Objective To address challenges in large-scale electronic health record (EHR) data exchange, we sought to develop, deploy, and test an open source, cloud-hosted app ‘listener’ that accesses standardized data across the SMART/HL7 Bulk FHIR Access application programming interface (API).
Methods We advance a model for scalable, federated, data sharing and learning. Cumulus software is designed to address key technology and policy desiderata including local utility, control, and administrative simplicity as well as privacy preservation during robust data sharing, and AI for processing unstructured text.
Results Cumulus relies on containerized, cloud-hosted software, installed within a healthcare organization’s security envelope. Cumulus accesses EHR data via the Bulk FHIR interface and streamlines automated processing and sharing. The modular design enables use of the latest AI and natural language processing tools and supports provider autonomy and administrative simplicity. In an initial test, Cumulus was deployed across five healthcare systems each partnered with public health. Cumulus output is patient counts which were aggregated into a table stratifying variables of interest to enable population health studies. All code is available open source. A policy stipulating that only aggregate data leave the institution greatly facilitated data sharing agreements.
Discussion and Conclusion Cumulus addresses barriers to data sharing based on (1) federally required support for standard APIs (2), increasing use of cloud computing, and (3) advances in AI. There is potential for scalability to support learning across myriad network configurations and use cases.
Competing Interest Statement
Boston Children's Hospital receives philanthropic contributions on behalf of the laboratory of K.D.M. from the SMART Advisory Committee with members including Microsoft, Cambia, Humana, and HCA Healthcare.
Funding Statement
This work was supported by: The Office of the National Coordinator of Health Information Technology contract numbers 90AX0031/01-00, 90AX0022/01-00, and 90AX0040/01-00; Centers for Disease Control and Prevention of the United States Department of Health and Human Services (HHS) as part of a financial assistance award, Strengthened Community Partnerships for More Holistic Approaches to Interoperability totaling $1,985,178. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by the CDC Foundation, CDC/HHS, or the U.S. Government; The National Center for Advancing Translational Sciences/National Institutes of Health Cooperative Agreements U01TR002623 and U01TR002997; National Association of Chronic Disease Directors/Centers for Disease Control and Prevention Grant No. NU38OT000286; Centers for Disease Control and Prevention Grant No. U18DP006500; Centers for Disease Control and Prevention Cooperative Agreement No. NU58IP000004, 1U01TR002997-01A1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Centers for Disease Control and Prevention contract supporting the work was administered through the CDC Foundation which interpreted federal requirements and classified the study as public health non-research that does not involve human participants and thus is exempt from human subjects research requirements. This determination was shared with the Boston Children's Hospital Committee on Clinical Investigation, who concurred. The decision was communicated to all site principal investigators.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
